Activated microglia represent a major source of inflammatory factors in Alzheimer's disease and a possible source of cytotoxic factors. β-Amyloid (Aβ) peptide, the predominant component in amyloid plaques, has been shown to activate microglia and stimulate their production of inflammatory factors. The present study was performed to analyze the responses of microglia to different forms of Aβ, with regard to release of the proinflammatory cytokines interleukin-1α (IL-1α), IL-1β, tumor necrosis factor-α (TNF-α), IL-6, and interferon-γ (IFN-γ), as well as the IL-1 receptor antagonist (IL-1ra). Primary cultures of microglia from rat neonatal cerebral cortex were incubated with freshly dissolved Aβ 1-40 or Aβ 1-42 , Aβ 1-40 fibrils, Aβ 1-40 βamy balls, or vehicle. Aβ 1-40 fibrils did not significantly stimulate any of these cytokines. Freshly dissolved Aβ 1-40 resulted in a marked increase in the release of IL-1β, and freshly dissolved Aβ 1-42 significantly stimulated both IL-1α and IFN-γ secretion. The Aβ 1-40 βamy balls stimulated the secretion of IL-1α and IL-1β. Incubation with Aβ peptides did not affect the secretion of IL-1ra, IL-6, or TNF-α. In the case of IL-1β, the response is correlated with the presence of Aβ peptide as monomers and oligomers.
Introduction
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common form of dementia in the elderly. An inflammatory component in AD and the possibility that nonsteroidal anti-inflammatory drugs (NSAIDs) can be used to treat AD patients was suggested by McGeer in 1990 (McGeer et al., 1990 . Epidemiological studies demonstrated a decreased prevalence of AD in patient populations treated with NSAIDs (see Szekely et al., 2004) . However, prospective studies do not support a marked beneficial effect of NSAIDs in AD (see, e.g., Aisen et al., 2003) . Activated astrocytes and microglia surrounding the amyloid plaques represent clear evidence for neuroinflammation in the AD brain. The reactive glial cells produce cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor-α (TNF-α) (Griffin et al., 1989; Bauer et al., 1991; Dickson et al., 1993) , as well as *Author to whom all correspondence and reprint requests should be addressed. E-mail: catharina.lindberg@neurotec.ki.se † Present address: Karolinska Institutet, Neurotec Department, Division of Experimental Geriatrics, Novum 4th Floor, Sweden. chemokines, complement factors, and acute-phase reactants (Vandenabeele and Fiers, 1991; Eikelenboom et al., 1994; Neuroinflammation Working Group, 2000; McGeer and McGeer, 2003) . Furthermore, elevated levels of IL-1β (Cacabelos et al., 1991; Blum-Degen et al., 1995) and TNF-α (Tarkowski et al., 1999) have been observed in serum and cerebrospinal fluid (CSF) from AD patients, whereas the levels of IL-6 have been shown to be either increased or unaltered as compared with healthy, age-matched controls (Blum-Degen et al., 1995; Hampel et al., 1997; Martinez et al., 2000; see also Neuroinflammation Working Group, 2000) . Significant activation of microglia appears to occur at an early stage of the disease, that is, before severe cognitive decline has occurred (Vehmas et al., 2003) .
There is ample evidence that β-amyloid (Aβ) peptide, the major component of amyloid plaques, stimulates the activation of microglia, leading to increased synthesis and release of proinflammatory cytokines (Araujo and Cotman, 1992; Del Bo et al., 1995) , as well as cytotoxic factors such as proteolytic enzymes, nitric oxide, quinolinic acid, glutamate, and reactive oxygen species (see Benveniste et al., 2001) . Some of these microglial products might be responsible for the indirect neurotoxic effects of Aβ (Selkoe, 1994; Giulian et al., 1996) .
New findings are highlighting the complexity and difficulties in establishing which form(s) of Aβ are responsible for its neurotoxic effects, and a better insight into the dynamic equilibrium between various Aβ forms is emerging. Aβ is a 39-to 42-aminoacid cleavage product from the amyloid precursor protein (APP). Aβ 1-42 is the major Aβ species in the AD brain (Roher et al., 1993; Näslund et al., 2000; Ingelsson et al., 2004) , and because of its high aggregation potential (Jarrett et al., 1993) , it is the major Aβ peptide deposited in amyloid plaques (Iwatsubo et al., 1994) . Aβ 1-40 has a significantly lower aggregation potential than Aβ 1-42 (Jarrett et al., 1993) and is the dominating form of Aβ found in plasma and CSF from AD patients (Vigo-Pelfrey et al., 1993; Scheuner et al., 1996) . Despite this, the observation has been made that more microglia are attracted to plaques that contain Aβ 1-40 (Mann et al., 1995; Fukumoto et al., 1996) . The amount of Aβ that is plaque bound in the AD brain exceeds soluble Aβ by a factor of 200-1000 (Ingelsson et al., 2004) . However, soluble Aβ is believed to accumulate in the extracellular matrix, where it might reach significant concentrations, and where mobility, in contrast to plaques, could be toxic to surrounding cells. A soluble pool of Aβ is extractable in physiological buffers from AD brain tissue (Ingelsson et al., 2004) . From this Aβ pool, or from AD brain sections, Aβ oligomers have been identified (Gong et al., 2003; Kayed et al., 2003) . In vitro studies on soluble Aβ oligomers have shown a range of biological actions, including neurotoxicity (Aksenova et al., 1996; Hartley et al., 1999; Dahlgren et al., 2002; Selkoe 2002; Hoshi et al., 2003) , and a disruptive effect on long-term potentiation (Wang et al., 2002; Walsh et al., 2004) .
Because focus has shifted from amyloid plaques to Aβ oligomers in explaining some of the AD-related neuropathology and because it is not sufficiently clear which form(s) of Aβ activates microglia, we set out to determine to what extent different forms of Aβ 1-40 and Aβ 1-42 affect microglia and the release of the proinflammatory cytokines IL-1α, IL-1β, IL-6, TNF-α, and interferon-γ (IFN-γ), as well as the endogenous IL-1 receptor antagonist (IL-1ra), from rat cortical microglia in vitro. Freshly dissolved Aβ 1-40 and Aβ 1-42 , as well as Aβ 1-40 fibrils and Aβ 1-40 βamy balls, were tested. βamy balls are supramolecular spherical structures, about 20-200 µm in diameter, spontaneously formed in vitro from synthetic Aβ 1-40 (Westlind-Danielsson and Arnerup, 2001 ). This form of Aβ 1-40 peptide was included to determine whether it affects microglial release of cytokines, despite the minimal external surface area of Aβ 1-40 peptide in a βamy ball, similar to Aβ deposits in amyloid plaques in vivo.
Polyvinylidene difluoride (PVDF) membrane was obtained from Millipore A/S (Glostrup, Denmark). Rabbit IL-1β and IL-1ra antibodies were generously provided by Professor S. Svensson (see Schultzberg et al., 1995) . Mouse ED1 antibodies were obtained from Serotec (Oxford, UK), and monoclonal antibodies raised against residues 1-16 of Aβ (6E10) were obtained from Signet Laboratory (Dedham, MA). Rabbit anti-glial fibrillary acidic protein (GFAP) antibodies, rabbit anti-mouse IgG conjugated with horseradish peroxidase (HRP), fluorescence antifading mounting medium, and normal sera (NS) were obtained from DakoCytomation Denmark A/S (Glostrup, Denmark). Goat anti-rabbit IgG coupled with AlexaGreen was purchased from Molecular Probes (Leiden, The Netherlands), and Cy3-conjugated goat anti-mouse IgG was obtained from Jackson ImmunoResearch Laboratories (West Grove, PA). Chemiluminescence substrate, ECL, was obtained from Amersham Biosciences (Piscataway, NJ). Lipopolysaccharide (LPS) was obtained from SigmaAldrich (Stockholm, Sweden). All other organic reagents were purchased from VWR International AB (Stockholm, Sweden).
Microglial Cultures
Pregnant Wistar rats, purchased from BK Universal AB (Sollentuna, Sweden), were kept under controlled light/dark conditions with food and water available ad libitum. The animal experiment procedures were approved by Stockholm South local committee on ethics of animal experiments (S113/01). Microglial cells were obtained from brains of neonatal rats, as described previously (Flavin and Ho, 1999) , with some modifications. Briefly, cerebral cortices were isolated from Wistar rats at postnatal day 0-2. Meninges and blood vessels were removed, and cortical tissue was minced with a pair of scissors and then passed through a stainless-steel mesh. Following trituration, performed to obtain a single-cell suspension, the cells were centrifuged 3 × 10 min at 250g, with resuspension in medium between centrifugations. The final cell suspension was plated in 75-cm 2 flasks, and the cultures maintained in DMEM/F12 supplemented with 10% FBS, 1% PEST, and 1% glutamine in a 5% CO 2 atmosphere at 37ºC. The medium was exchanged 1 d after plating and then every fourth day. The mixed glial (astrocytes and microglia) cultures were kept in the incubator for approx 12-13 d. Microglial cells were isolated by shaking for 60 min at 180 rpm. The medium was collected and centrifuged at 250g for 10 min, and the pellet was resuspended in complete medium supplemented with N2. The resulting cell suspension was seeded into chamber slides at a known density, which varied between experiments in the range of 18,500-37,500 cells per well. The microglial cultures were maintained for 2 d before treatment. The purity of the cultures was determined by staining with the microglial marker ED1 and the astrocytic marker GFAP.
Cell Stimulation
Human Aβ 1-40 and Aβ 1-42 peptides were dissolved in distilled H 2 O and then diluted in phosphatebuffered saline (PBS) immediately prior to use or incubation for the formation of fibrils or βamy balls. The fibrils and the βamy balls were obtained as described previously (Westlind-Danielsson and Arnerup, 2001 ). Briefly, Aβ 1-40 peptide was dissolved in double-distilled water and an equal volume of 2 × PBS (final concentration, 50 mM Na 2 HPO 4 × NaH 2 PO 4 (pH 7.4) and 0.1 M NaCl). The solution was incubated statically in Eppendorf tubes (fibrils) or Nanosep microconcentrator vials (βamy balls) at 30ºC in the dark for 8 d. To obtain fibrils, the resulting solution was centrifuged for 10 min and the pellet resuspended in PBS (0.05 M), sonicated for a few seconds, and added to the cultures. To verify that Aβ 1-40 βamy balls had formed, small aliquots were stained with toluidine blue and analyzed in a Nikon light microscope, before adding to the microglial cultures.
To treat the microglia, the culture medium was removed and replaced by fresh medium, to which one of the forms of Aβ was added. A dose-response curve was performed with 10, 25, 50, 75, and 90 µM freshly dissolved Aβ 1-40 . For control treatment, an equal volume of vehicle, that is, 0.05 M PBS (pH 7.4), was added to the medium. Incubation of the microglial cells with different forms of Aβ peptides, that is, freshly dissolved Aβ 1-40 or Aβ 1-42 , Aβ 1-40 fibrils or Aβ 1-40 βamy balls, was performed at a concentration of 75 µM. Each condition was carried out in eight wells, and each experiment was performed as six independent experiments, or five in the case of treatment with Aβ 1--42 . Based on previous studies with Aβ treatment of microglia (see, e.g., Araujo and Cotman, 1992) , 24-h exposure (at 37 o C) was chosen for the present experiments.
A dose-response curve for LPS (10, 100, and 500 ng/mL) was performed to obtain a positive control for cytokine secretion from the microglial cells. Vehicle, that is, culture medium (DMEM/F12), served as control.
Cell Counts
To take into account the variation between experiments in the number of cells seeded and a possible cell loss, the total number of cells was assessed at the end of each experiment. The cells were randomly counted in seven fields of 1.5 mm 2 in each of three wells per treatment. From these data, the total number of cells per well was calculated. The resulting values were used to calculate the survival of cells and the amount of cytokine released per cell.
Measurements of Cytokine Secretion
Culture medium was collected after 24 h of incubation, snap frozen in liquid nitrogen, and stored at -70ºC until use. All samples were centrifuged before analysis. Secretion of IL-1β and IL-1ra to the medium was assessed by commercially available ELISA kits, according to the manufacturer's protocols. For each set of experiments, standard curves were run. The medium served as a blank for the IL-1β assay and a chromogen blank was used for the IL-1ra assay and the blank was then subtracted from readings of the experimental samples. Secretion of IL-1α, IL-1β, IL-6, TNF-α, and IFN-γ to the culture medium was analyzed by a Bio-Plex rat cytokine 5-plex panel according to the manufacturer's protocol, with the medium serving as blank and diluent for the standard.
Gel Electrophoresis and Immunoblot
Samples of freshly dissolved Aβ 1-40 (75 µM) and Aβ 1-42 (75 µM), respectively, were incubated at 37ºC in the absence of microglia for 0, 5.5, 12, 18 (only Aβ 1-40 ), and 24 h, in the culture medium (DMEM/F12) used for the microglial cells. In view of previous findings that Aβ 1-40 oligomers are not as stable as those formed by Aβ 1-42 oligomers (Päiviö et al., 2004) , an aliquot of each sample was treated with a cross-linker, glutaraldehyde, prior to Western blot analysis.
The samples were diluted 1:3 (Aβ 1-40 ) and 1:5 (Aβ 1-42 ) in DMEM/F12, and half of the sample from each time point was fixed for 10-15 s in 2.5% glutaraldehyde. Culture medium, fixed and nonfixed, was included as controls. The proteins were separated by SDS-PAGE, and Western blotting was performed as described previously (Dahlgren et al., 2002) . Briefly, 20 µL of each sample was added to the sample buffer and applied to a 12% bis-Tris NuPage gel using MES running buffer. The amount of Aβ peptide loaded to each well was 2.2 µg (Aβ 1-40 ) and 1.4 µg (Aβ 1-42 ). SeeBlue prestained marker was used for estimation of molecular weights. The proteins were separated at 200 V for 1 h and transferred to a 0.22-µm PVDF membrane at 20 V for 35 min. The membranes were incubated for 1 h at room temperature (RT) in 5% nonfat dry milk dissolved in Trisbuffered saline (20 mM at pH 7.6, 137 mM NaCl) containing 0.0625% Tween-20. The resulting blots were incubated with 6E10 monoclonal antibodies to Aβ 1-16 (dilution 1:1000) in blocking buffer overnight at 4 o C. The membrane was washed three times and incubated with rabbit anti-mouse IgG conjugated with HRP (dilution 1:2000) for 1 h at RT, and washed three times. The proteins were visualized with chemiluminescence substrate following the manufacturer's instructions (ECL, Amersham).
Immunocytochemistry
Cells were fixed with 4% paraformaldehyde solution in 0.1 M Sörensen phosphate buffer for 20 min at RT after 24 h incubation with Aβ peptides. After rinsing in 0.01 M PBS for 3 × 10 min, the cells were stored in PBS at 4ºC until use. Unspecific staining was blocked by incubation with NS for 30 min at RT, followed by incubation overnight at 4ºC with a mixture of GFAP and ED1 antibodies (dilution 1:2000 of each), or with anti-serum to IL-1β (dilution 1:4000) or IL-1ra (dilution 1:400). The cells were then washed in PBS and incubated for 1 h at RT with a mixture of Cy3-conjugated anti-mouse IgG (1:2000) and AlexaGreen-conjugated anti-rabbit IgG (1:1000) for detection of ED1 and GFAP, or with AlexaGreen -conjugated anti-rabbit IgG (1:1000) for detection of IL-1β and IL-1ra. The cells were rinsed in PBS, mounted with antifade mounting medium, and examined under a fluorescence microscope (Nikon Eclipse E800), equipped with appropriate filters. Omission of the primary antibodies served as negative controls.
Data Analysis
The secretion of cytokines from microglial cells after incubation with Aβ peptides was related to the number of cells. To account for possible variations owing to different numbers of cells seeded in the experiments, the amount of secreted cytokine per cell is expressed as percent of the secretion per cell upon incubation with vehicle. In cases where the level of cytokine secretion was below the range of the standard curve, the values were set to the minimum detection level of the standard curve. The data on secreted cytokines were analyzed using the The cell culture medium collected at 24 h after addition of vehicle had detectable basal levels of the proinflammatory cytokines IL-1α, IL-1β, IFN-γ, IL-6, and TNF-α and of the anti-inflammatory cytokine IL-1ra (see Table 1 ). Incubation of microglial cells with different aggregational forms of Aβ peptides resulted in increased secretion of these basal levels for some of the cytokines studied (Fig. 2) .
The effects of different forms of Aβ peptides with regard to the release of IL-1α, IL-1β, IFN-γ, IL-6, TNF-α and IL-1ra were determined as pg/cell (mean ± S.E.M.) and expressed as percent of vehicle (set to 100%). Freshly dissolved Aβ 1-42 (13666.7 ± 10977.0, p < 0.01) and Aβ 1-40 βamy balls (3442.0 ± 2968.7, p < 0.005) significantly increased IL-1α release as compared with vehicle, whereas freshly dissolved Aβ 1-40 (13827.0 ± 10141.9) and Aβ 1-40 fibrils (18549.6 ± 17953. 8) gave rise to a statistically insignificant increase (p = 0.0547) (Fig. 2A) .
Freshly dissolved Aβ 1-40 gave rise to a statistically significant increase in IL-1β secretion as compared with vehicle (3851.9 ± 1979.1, p < 0.05 [ Fig. 2B]) . Incubation with Aβ 1-40 βamy balls also resulted in a significant increase in IL-1β secretion as compared with vehicle (488.2 ± 282.5, p < 0.005), whereas neither Aβ 1-40 fibrils (371.5 ± 172.9) nor freshly dissolved Aβ 1-42 (210.0 ± 88.7) resulted in a significant increase (Fig. 2B) .
The secretion of IFN-γ was significantly increased after incubation with freshly dissolved Aβ 1-42 as compared with vehicle (1620.0 ± 1076.5, p < 0.01 [ Fig. 2C] ). Incubation with Aβ 1-40 βamy balls (969.2 ± 529.6), Aβ 1-40 fibrils (772.5 ± 484.8), or freshly dissolved Aβ 1-40 (74.1 ± 13.8) did not significantly alter the secretion of IFN-γ as compared with vehicle (Fig. 2C) .
nonparametric Kruskal-Wallis test, followed by the Mann-Whitney test for individual comparison of each Aβ-treated group with the vehicle group. The statistical significance was established at a level of p < 0.05.
Results
Primary cultures of microglial cells were obtained from neonatal rat cerebral cortex, and staining with markers for astrocytes (GFAP) and microglia (ED1) showed that at least 95% of the cells represented microglia. Cultures incubated with vehicle (control cultures), that is,complete DMEM/F12 medium containing N2 supplement, formed a monolayer of cells with a slender, elongated shape. Incubation with different forms of Aβ peptides did not alter cell survival significantly, as determined from the number of cells seeded and the number of cells remaining after treatment (data not shown). The effects of the different forms of Aβ, with regard to expression and release of cytokines, are described below.
Secretion of Cytokines
The dose-response curve performed with different concentrations of freshly dissolved Aβ 1-40 resulted in a marked increase in IL-1β secretion at 75 and 90 µM Aβ 1-40 (Fig. 1) . On the basis of these results, the concentration of 75 µM was chosen for the experiments. The amount IL-1β secreted upon incubation with Aβ 1-40 was similar to the amount released upon LPS (100 and 500 ng/mL) treatment (data not shown). The release of IL-6, TNF-α, and IL-1ra from microglial cells was not significantly altered upon incubation with the different forms of Aβ peptide as compared with vehicle (data not shown).
Gel Electrophoresis and Immunoblot
Western blotting was performed to identify the aggregational forms to which the microglial cells were exposed during the 24-h incubation with freshly dissolved Aβ 1-40 (Fig. 3) or Aβ 1-42 (Fig. 4) . The incubation parameters were the same as those used in the presence of microglia. Directly after incubation an aliquot of each sample was exposed briefly to glutaraldehyde, which freezes the Aβ species in the tube (see Figs. 3 and 4) . For comparison, aliquots of each sample not exposed to glutaraldehyde were also run (Figs. 3 and 4) . Differences were observed with regard to the bands generated by Aβ 1-40 or Aβ 1-42 , respectively. Monomer bands were observed at approx 4 kDa for all incubation times for Aβ (Fig. 3) and for the 0-and 5.5-h time points for Aβ 1-42 (Fig. 4A) .
After treatment of the Aβ 1-40 samples with glutaraldehyde, three additional bands corresponding to the size of dimers (8632 Daltons), dodecamers (51,792 Daltons), and 24-mers (103,584 Daltons) were seen at all time points except 24 h (Fig. 3) . A timedependent increase in 24-mer band intensity was observed up to the 18-h time point. At 18 and 24 h, an additional band can be seen at the site of the loading well for samples fixed with glutaraldehyde and at 24 h also for the nonfixed sample (Fig. 3) .
In the case of Aβ 1-42 , bands corresponding to the size of trimer (13,545 Daltons) and tetramer (18,060 Daltons) bands were seen at all incubation times, with a marked decrease in intensity between 0 and 5.5 h (Fig. 4) . After treatment with glutaraldehyde the trimer bands were less intense, whereas the tetramer bands were more intense than without this treatment (Fig. 4B) . In addition, an intense band was seen at the size of hexamer (27,090 Daltons) at 0 h and a faint band of this size was still visible at 5.5 and 12 h (Fig. 4) . Large oligomers within the molecular mass range of approx 40-75 kDa were present at all time points, whereas only small amounts of monomers were found in the preparation at 12-24 h (Fig. 4B) .
No bands were visible for the culture medium without addition of Aβ peptides (Figs. 3 and 4) .
Cellular Expression of Cytokines
Immunocytochemical analysis of microglial cell cultures showed expression of IL-1β and IL-1ra (data not shown) in the cytoplasm. The signal intensity for IL-1β and IL-1ra was similar after incubation with the different forms of Aβ-peptides, as compared with the signal intensity after incubation with vehicle. No labeling could be seen after omission of IL-1β or IL1ra antiserum (data not shown).
Discussion
It is well documented that Aβ peptides induce cytokine synthesis and release from microglia (Araujo and Cotman, 1992; Meda et al., 1995; Murphy et al., 1998; Combs et al., 2001; Szczepanik et al., 2001; Lee et al., 2002; Takata et al., 2003) , monocytes (Lorton et al., 1996; Combs et al., 2001; Smits et al., 2001) , and astrocytes (Del Bo et al., 1995; Gitter et al., 1995; Hu et al., 1998; Isobe et al., 2000) . Firm identification of the forms of Aβ that are most efficacious in stimulating microglia has awaited clarification. It is conceivable that each form of Aβ stimulates a specific inflammatory response, with regard to the 8 Lindberg et al.
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profile of secreted cytokines and other inflammatory or cytotoxic factors. The present study showed differential effects on microglial secretion of cytokines, depending on the Aβ peptide species and aggregational form. Increased knowledge regarding the complexity of Aβ protein chemistry and fibrillization (Harper et al., 1997; Walsh et al., 1997; Palmblad et al., 2002; Päiviö et al., 2004) indicates that Aβ oligomers might interfere with synaptic transmission (Lambert et al., 1998; Cleary et al., 2005; Walsh et al., 2004) and cause neurotoxicity (Aksenova et al., 1996; Hartley et al., 1999; Dahlgren et al., 2002; Selkoe, 2002; Hoshi et al., 2003) . The cell culture medium in which the experiments were conducted promoted the formation of monomers and several oligomeric forms, that is, dimers, dodecamers, and 24-mers, visualized by treating the sample with a cross-linker. Cross-linking with glutaraldehyde helps to freeze the sample (Levine, 1995; Bitan and Teplow, 2004) , predominantly hindering the shift of the equilibrium of the Aβ polymerization reaction that might occur during sample handling and by the denaturing conditions of the electrophoresis procedure. In the case of Aβ 1-42 , progressive fibrillization during sample handling is indicated by the low levels seen already at 5.5 h as compared with 0 h. The concentration of Aβ was chosen on the basis of dose-response curve to IL-1β, and although 75 µM is high, it might be required to obtain sufficient levels of the oligomers, if oligomers represent the main form that stimulates microglial activation in terms of cytokine secretion.
Freshly dissolved Aβ 1-40 , generating a population of oligomers and monomers that seem to persist in the cell medium throughout the main part of the incubation period, was a very potent preparation in mediating IL-1β release from microglia. The preformed Aβ 1-40 βamy balls resulted in a statistically although less marked effect on IL-1β secretion. Neither the highly aggregation-prone Aβ 1-42 nor Aβ 1-40 fibrils stimulated the secretion of IL-1β, suggesting that the signaling pathway for IL-1β in rat microglia is not responsive to fibrillary forms of Aβ peptides. The results are in line with findings showing that microglia are more attracted to Aβ 1-40 -containing plaques, than to plaques containing only Aβ 1-42/43 (Mann et al., 1995; Fukumoto et al., 1996) .
The microglial release of IL-1α and IFN-γ was significantly stimulated by freshly dissolved Aβ 1-42 . In the case of IL-1α, the findings are in agreement with studies demonstrating the association of IL-1α-positive microglia with diffuse amyloid plaques (Griffin et al., 1995) , shown to be composed mainly of N-truncated Aβ 1-42 (Kumar-Singh et al., 2000) . Exposure of the cells to the preformed Aβ 1-40 βamy balls resulted in a small but significant release of IL-1α, whereas freshly dissolved Aβ 1-40 and Aβ 1-40 fibrils gave rise to an increased, albeit nonsignificant, secretion. Our Western blot data indicate that Aβ 1-42 formed fibrils rapidly with a quick transition from trimers and tetramers, oligomeric species that are distinct from those seen formed from Aβ 1-40 . The results would seem to suggest that during the 24-h incubation period both IL-1α and IFN-γ respond to a mixture of Aβ 1-42 oligomers and fibrils, including tetramers that appeared to dominate in the medium after incubation for at least 5.5 h.
None of the Aβ-peptide forms was found to stimulate the release of IL-6 or TNF-α from rat cortical microglia, in agreement with findings by Takata et al. (2003) . Similarly, the release of IL-1ra was unaffected by the different forms of Aβ peptide. This finding might be explained by a delay in the synthesis of this endogenous receptor antagonist as compared with IL-1β, as seen in in vivo models of neurodegeneration (see, e.g., Eriksson et al., 1999) . Analysis of IL-1ra in CSF samples from AD patients showed either no difference (Lanzrein et al., 1998) or a decrease (Tarkowski et al., 2001) in the levels, as compared with control subjects.
The neurotoxic effects of Aβ peptides have been the subject of many studies (see, e.g., Selkoe, 2002) , one hypothesis being that the Aβ-stimulated activation of microglia and the release of inflammatory factors are involved in this neurotoxicity. In vitro studies have demonstrated that IL-1β stimulates the synthesis of APP in neurons (Forloni et al., 1992; Del Bo et al., 1995) and that IFN-γ stimulates the production of Aβ 1-40 and Aβ 1-42 in human neuroblastoma SK-N-SH cells (see Blasko et al., 2001) . Increased expression of IFN-γ mRNA and gene product was observed in reactive microglia and astrocytes around the amyloid deposits in transgenic mice Tg2576, expressing the Swedish mutation in APP (Abbas et al., 2002) , whereas analysis of serum and CSF samples have not, so far, provided evidence for increased levels of IFN-γ in AD (Singh and Guthikonda, 1997; Engelborghs et al., 1999; Solerte et al., 2000) . Interestingly, IFN-γ has been shown to reduce the secretion of soluble APPα (see Blasko et al., 2001 ), considered as a neuroprotective fragment of APP (Mattson et al., 1993) . It should be noted that the role of microglial activation is not fully understood and that in addition to producing inflammatory and cytotoxic factors, activated microglia are phagocytic. Thus, they might contribute to clearance of Aβ and amyloid plaques (Ard et al., 1996; Bard et al., 2000) .
In conclusion, based on statistical significance, freshly dissolved Aβ peptides were found to be more potent than other forms in stimulating some of the inflammatory response from rat cortical microglia. It appears that the dynamic mixture of monomers, oligomers, and protofibrils, present during the 24-h incubation with freshly dissolved Aβpeptides, resulted in an increased release of IFN-γ, IL-1α, and IL-1β of which the latter two cytokines have been shown to be expressed in microglia in the AD brain (Griffin et al., 1989 (Griffin et al., , 1995 . The finding that freshly dissolved Aβ 1-40 and Aβ 1-42 stimulated certain inflammatory cytokines might support the involvement of these cytokines in an early stage of AD, in agreement with the findings that there is significant activation of microglia in early stages of the disease, that is, before severe cognitive decline has occurred (Vehmas et al., 2003) .
